RICO Class Action Filed Against 3 Insulin Makers For Gaming Prices

(February 1, 2017, 8:13 AM EST) -- BOSTON — Eleven diabetics on Jan. 30 filed a class action complaint alleging that Sanofi U.S., Novo Nordisk Inc. and Eli Lilly and Co. are raising their prices for insulin out...

To view the full article, register now.